Predict response to immune checkpoint inhibition in acute myeloid leukemia (AML) using biomarkers
Naval G. Daver
Immunotherapy highlights from ICML 2017
Panel discussion on immune therapies for lymphoma - CAR T-cell therapy and the question of cure
Anas Younes et al.
Myeloma highlights from ASCO 2017
Immunotherapy for the treatment of multiple myeloma